{"gene":"SCN3A","run_date":"2026-06-10T07:46:29","timeline":{"discoveries":[{"year":2001,"finding":"Nav1.3 channels expressed in HEK293 cells generate fast-activating and fast-inactivating currents with rapid repriming at negative potentials, slow closed-state inactivation, and large ramp currents in response to slow depolarizations. Coexpression of β3 subunits had small but significant effects on kinetic and voltage-dependent properties, while β1 and β2 subunits had little or no effect. Repriming kinetics were twofold faster when Nav1.3 was expressed in SNS-null DRG neurons compared to HEK293 cells, demonstrating that cellular background modulates channel properties.","method":"Whole-cell patch clamp electrophysiology in HEK293 cells and SNS-null DRG neurons (via biolistics); TTX-resistant Nav1.3 mutant construct; coexpression of β subunits","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiological characterization with multiple conditions, subunit coexpression, and cell-type comparison in a single rigorous study","pmids":["11487618"],"is_preprint":false},{"year":2002,"finding":"Human Nav1.3 expressed in CHO cells forms rapidly inactivating channels. Coexpression of β1 or β3 subunits shifted the inactivation curve ~10 mV negative and slowed repriming ~3-fold, whereas β2 had no effect alone or in combination with β1 or β3.","method":"Whole-cell patch clamp electrophysiology in stably transfected CHO cells; coexpression of β1, β2, and β3 subunits","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiological characterization with multiple subunit conditions, independent replication of β-subunit effects consistent with PMID:11487618","pmids":["12220575"],"is_preprint":false},{"year":2003,"finding":"Intrathecal antisense oligodeoxynucleotides targeting Nav1.3 reduced Nav1.3 mRNA and protein in dorsal horn neurons, decreased hyperexcitability of multireceptive nociceptive neurons, and attenuated mechanical allodynia and thermal hyperalgesia after spinal cord injury (SCI) in rats. Effects reversed after cessation of antisense delivery, establishing a functional link between Nav1.3 upregulation in second-order dorsal horn neurons and central neuropathic pain after SCI.","method":"Intrathecal antisense ODN knockdown; extracellular electrophysiological recordings of dorsal horn neurons; quantitative RT-PCR, in situ hybridization, immunocytochemistry; behavioral pain assays in rat SCI model","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — antisense knockdown with multiple orthogonal readouts (molecular, electrophysiological, behavioral), reversal controls included","pmids":["14523090"],"is_preprint":false},{"year":2003,"finding":"Lidocaine inhibited peak Nav1.3 current, shifted steady-state inactivation to hyperpolarized potentials, and delayed recovery from inactivation in Xenopus oocytes. These effects were attenuated by coexpression of β1 or β3, with β1 producing greater attenuation including reduced use-dependent block.","method":"Two-electrode voltage clamp in Xenopus oocytes; coexpression of β1 and β3 subunits; use-dependent block protocol","journal":"European journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous electrophysiology but single study, Xenopus oocyte system","pmids":["12706451"],"is_preprint":false},{"year":2004,"finding":"Contactin coimmunoprecipitates with Nav1.3 from postnatal rat brain and from HEK293 cells stably expressing Nav1.3. GST fusion proteins of the N and C termini of Nav1.3 pull down contactin from HEK293 cell lysates. Cotransfection of contactin increases Nav1.3 current amplitude ~3-fold without changing biophysical channel properties. Enzymatic removal of contactin from the cell surface did not reduce elevated Nav1.3 current, suggesting contactin increases intracellular channel density at the surface rather than acting as a direct extracellular modulator.","method":"Co-immunoprecipitation from rat brain and HEK293 cells; GST pulldown; whole-cell patch clamp; enzymatic contactin removal; immunocytochemistry","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP and GST pulldown plus functional electrophysiology and enzymatic removal experiment, multiple orthogonal methods in one study","pmids":["15317864"],"is_preprint":false},{"year":2005,"finding":"After spinal cord contusion injury in rats, Nav1.3 protein is upregulated in thalamic VPL and VPM neurons, and these neurons show increased spontaneous discharge, afterdischarge, hyperresponsiveness to peripheral stimuli, and expanded receptive fields. Intrathecal antisense ODNs targeting Nav1.3 reduced Nav1.3 expression in thalamic neurons and reversed these electrophysiological alterations, linking Nav1.3 upregulation to altered thalamic somatosensory processing after SCI.","method":"Intrathecal antisense ODN knockdown; extracellular unit recordings in thalamic VPL neurons; immunocytochemistry; spinal cord transection control experiment in rats","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — antisense knockdown with electrophysiological reversal and anatomical controls, multiple orthogonal readouts","pmids":["16109750"],"is_preprint":false},{"year":2006,"finding":"Nav1.3 vasa recta (descending vasa recta) pericyte currents are regulated by calmodulin (CaM): CaM binds to the C-terminal domain of Nav1.3 via pulldown and co-immunoprecipitation assays. Calmodulin inhibitory peptide (CIP) and the CaM inhibitor W7 suppressed Nav1.3 currents in patch clamp. Raising intracellular Ca2+ from 20 to ~2000 nM produced a depolarizing shift in Nav1.3 activation.","method":"RT-PCR identification of Nav1.3 in DVR; immunoblot and immunofluorescence; GST-Nav1.3 C-terminal pulldown; co-immunoprecipitation; patch-clamp electrophysiology with CaM inhibitors and Ca2+ manipulation","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus GST pulldown plus functional electrophysiology, single lab, multiple orthogonal methods","pmids":["16912065"],"is_preprint":false},{"year":2008,"finding":"The novel SCN3A variant K354Q (K345Q in Nav1.3 DI/S5-6 linker) was identified in a pediatric epilepsy patient. Functional analysis in the Nav1.5 backbone demonstrated increased persistent current of a magnitude similar to epileptogenic SCN1A/SCN2A mutations, suggesting pathogenicity.","method":"Patient sequencing; heterologous functional expression and whole-cell patch clamp (in Nav1.5 backbone as surrogate)","journal":"Neuroscience letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — functional analysis performed in a surrogate channel backbone (Nav1.5), not directly in Nav1.3; single study","pmids":["18242854"],"is_preprint":false},{"year":2010,"finding":"The K354Q epilepsy-linked mutation directly assessed in Nav1.3 enhances both persistent and ramp currents of Nav1.3, reduces current threshold, and produces spontaneous firing and paroxysmal depolarizing shift-like complexes when Nav1.3/K354Q is expressed in hippocampal neurons.","method":"Site-directed mutagenesis; heterologous expression in HEK293 cells; whole-cell patch clamp; expression in hippocampal neurons by transfection","journal":"Experimental neurology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution with mutagenesis in native Nav1.3 backbone plus functional neuronal readout, single lab but two orthogonal systems (HEK + neurons)","pmids":["20420834"],"is_preprint":false},{"year":2010,"finding":"TNF-α upregulates Nav1.3 in DRG neurons: peri-sciatic administration of recombinant TNF-α without nerve injury upregulated Nav1.3 mRNA and protein and increased TTX-sensitive current densities in DRG neurons in vivo. TNF-α also dose-dependently enhanced Nav1.3 expression in cultured adult DRG neurons in vitro. Upregulation after L5 ventral root transection was significantly reduced in TNF receptor 1 knockout mice.","method":"In vivo recombinant TNF-α administration; in vitro DRG neuron culture with TNF-α; quantitative RT-PCR; immunocytochemistry; patch clamp; TNF receptor 1 knockout mice","journal":"Pain","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (in vivo, in vitro, KO mice), replicated across conditions","pmids":["20638792"],"is_preprint":false},{"year":2010,"finding":"Inhibition of NF-κB (via PDTC) prevented the re-expression of Nav1.3 induced by L5 ventral root transection and blocked the Nav1.3 upregulation caused by TNF-α in cultured DRG neurons, placing NF-κB downstream of TNF-α in the signaling pathway that drives Nav1.3 re-expression in sensory neurons after nerve injury.","method":"Intrathecal PDTC injection in rat VRT model; cultured adult DRG neurons treated with recombinant TNF-α ± PDTC; immunocytochemistry for Nav1.3; behavioral allodynia assays","journal":"Brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis by pharmacological NF-κB inhibition in vivo and in vitro, single lab, two complementary systems","pmids":["20858468"],"is_preprint":false},{"year":2010,"finding":"The β3 subunit depolarizes voltage sensitivity of Nav1.3 activation and inactivation, induces biphasic inactivation with a novel slower component, and increases the fraction of channels inactivating by the slower pathway. NMR/CD structural analysis of the β3 intracellular domain revealed a short amphipathic α-helix followed by a disordered region; both regions selectively stabilize fast inactivation of Nav1.3.","method":"Whole-cell patch clamp in HEK293 cells; CD and NMR spectroscopy of β3 intracellular domain; deletion mutagenesis of β3 intracellular regions","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — electrophysiology + NMR/CD structural analysis + mutagenesis, single lab but three orthogonal methods","pmids":["20675377"],"is_preprint":false},{"year":2011,"finding":"PKC inhibition (staurosporine or calphostin C) in Nav1.3-expressing CHO cells caused a depolarizing shift in voltage dependence and decreased current amplitude, demonstrating that Nav1.3 channel function is regulated by PKC. In neuropathic DRG neurons, PKC inhibition reduced P2X-evoked TTX-sensitive sodium channel activity and reversed hyperexcitability.","method":"Whole-cell patch clamp in CHO cells stably expressing Nav1.3; PKC inhibitors (staurosporine, calphostin C); patch clamp of DRG neurons from spinal nerve ligation model; in situ hybridization for Nav1.3","journal":"Molecular pain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct pharmacological modulation of Nav1.3 in stable cell line plus DRG recordings, single lab, two systems","pmids":["21314936"],"is_preprint":false},{"year":2011,"finding":"TNF-α-induced re-expression of Nav1.3 in cultured adult DRG neurons requires activation of both p38 MAPK and JNK: pharmacological inhibition of p38 MAPK (SB203580) or JNK (SP600125) dose-dependently blocked Nav1.3 re-expression triggered by recombinant TNF-α.","method":"Cultured adult rat DRG neurons; recombinant TNF-α treatment; p38 MAPK inhibitor SB203580 and JNK inhibitor SP600125; immunocytochemistry for Nav1.3","journal":"The Chinese journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological epistasis with two kinase inhibitors, in vitro single lab","pmids":["22129822"],"is_preprint":false},{"year":2012,"finding":"The Nav1.3 pharmacological modulator BmK AS (scorpion toxin, site 4-specific) hyperpolarized voltage dependence of steady-state activation and inactivation, accelerated recovery from inactivation, and preferentially inhibited slow inactivation over fast inactivation, suggesting BmK AS stabilizes both closed and open states of Nav1.3.","method":"Two-electrode voltage clamp in Xenopus oocytes expressing Nav1.3; concentration-response analysis of BmK AS","journal":"Neuroscience bulletin","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct electrophysiological characterization of toxin-Nav1.3 interaction, single lab, single system","pmids":["22622820"],"is_preprint":false},{"year":2013,"finding":"Four novel SCN3A missense variants (R357Q, D766N, E1111K, M1323V) and the previously reported K354Q variant, expressed as human Nav1.3 in heterologous cells, showed heterogeneous but overlapping functional defects. All variants shared increased current activation in response to depolarizing ramp voltages. R357Q had reduced current density and slower activation; E1111K produced increased persistent sodium current. This common ramp-current gain of function is consistent with neuronal hyperexcitability.","method":"Site-directed mutagenesis; heterologous expression of human Nav1.3 variants; whole-cell patch clamp in HEK293 or CHO cells","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct mutagenesis and electrophysiological characterization in native Nav1.3, multiple variants, single rigorous study","pmids":["24157691"],"is_preprint":false},{"year":2014,"finding":"In mouse pancreatic α-cells, Nav1.3 (Scn3a) is the predominant voltage-gated sodium channel α-subunit; genetic ablation of Scn3a reduces the α-cell Na+ current by 80%. In β-cells, knockout of Scn3a reveals a small Scn3a-dependent Na+ current component. Glucagon and insulin secretion are inhibited in Scn3a-/- islets, establishing Nav1.3 as functionally important for islet hormone secretion.","method":"Single-cell PCR; Scn3a knockout mice; patch clamp of isolated α- and β-cells; glucagon/insulin secretion assays from isolated islets","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with electrophysiological and secretion readouts, multiple orthogonal methods, single rigorous study","pmids":["25172946"],"is_preprint":false},{"year":2014,"finding":"CpG methylation of a specific site (-39C) in the Scn3a promoter represses promoter activity. MBD2 binds to the methylated -39C motif; knockdown of MBD2 in mouse cells led to -39C methylation and downregulation of Scn3a transcription. In seizure mice, demethylation of -39C and upregulation of Scn3a co-occur with decreased MBD2 binding, establishing an epigenetic CpG methylation/MBD2 mechanism for Scn3a expression control.","method":"Luciferase reporter assays; CpG methylation analysis; MBD2 knockdown in N1E-115 cells; chromatin pulldown/MBD2 binding assay; kainate seizure mouse model","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay + MBD2 knockdown + promoter methylation analysis, single lab, multiple orthogonal methods","pmids":["25459751"],"is_preprint":false},{"year":2014,"finding":"miR-96 directly inhibits Nav1.3 mRNA expression in embryonic DRG neurons in vitro and reduces Nav1.3 protein in DRG after CCI injury in vivo following intrathecal miR-96 administration.","method":"Intrathecal miR-96 delivery in CCI rat model; in vitro DRG neuron transfection; qRT-PCR and western blot for Nav1.3","journal":"Neurochemical research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro knockdown, molecular readouts, single lab","pmids":["24234845"],"is_preprint":false},{"year":2014,"finding":"Comparison of equivalent pore-region mutations in Nav1.1 (N301S) and Nav1.3 (N302S): SCN1A-N301S produced complete loss of function (no measurable sodium current), while SCN3A-N302S only slightly reduced channel activity, demonstrating that identical pore mutations have isoform-dependent electrophysiological consequences.","method":"Site-directed mutagenesis; heterologous expression; whole-cell patch clamp","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct mutagenesis and electrophysiology, single lab, single study","pmids":["24990319"],"is_preprint":false},{"year":2016,"finding":"Valproate (but not carbamazepine or lamotrigine) epigenetically downregulates Scn3a expression by inducing methylation at the -39C site in the Scn3a promoter, decreasing promoter activity. VPA downregulates MBD2 at the posttranscriptional level, and MBD2 knockdown increases Scn3a expression. VPA also upregulates FTO protein; FTO knockdown abolishes VPA's repressive effects on MBD2 and Nav1.3.","method":"Luciferase reporter assays; CpG methylation analysis; MBD2 and FTO knockdown in Neuro-2a cells; western blot; real-time PCR; seizure mouse model","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple knockdown experiments plus reporter assays, single lab, multiple orthogonal methods","pmids":["27013471"],"is_preprint":false},{"year":2016,"finding":"A loss-of-function SCN3A variant (L247P) traffics deficiently to the cell surface (demonstrated by cell surface biotinylation), producing no detectable sodium current in heterologous expression. Heterozygous Scn3a hypomorphic (Scn3a+/Hyp) mice showed increased susceptibility to electroconvulsive and chemiconvulsive seizures and deficits in locomotor activity and motor learning, establishing that reduced Nav1.3 activity can increase seizure susceptibility.","method":"Whole-exome sequencing; heterologous expression + whole-cell patch clamp; cell surface biotinylation; Scn3a hypomorphic mouse line (gene trap); seizure threshold assays (6Hz, flurothyl, kainic acid); behavioral testing","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional characterization of trafficking defect plus in vivo mouse model with multiple seizure paradigms, multiple orthogonal methods","pmids":["28235671"],"is_preprint":false},{"year":2016,"finding":"GAPDH binds to a conserved element in the 3' UTR of SCN3A mRNA, increasing Scn3a mRNA stability and expression. In seizure mice, upregulated and phosphorylated GAPDH enhances binding to the Scn3a 3' UTR, upregulating Scn3a. β-hydroxybutyric acid (produced by ketogenic diet) weakens GAPDH binding and rescues abnormal Scn3a expression.","method":"RNA-protein binding assays; mRNA stability assays; GAPDH knockdown; phosphorylation analysis; seizure and ketogenic diet mouse models; qRT-PCR","journal":"Neuropharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-protein binding and mRNA stability assays with functional knockdown, single lab, two conditions","pmids":["27816501"],"is_preprint":false},{"year":2017,"finding":"miR-30b overexpression attenuated Nav1.3 mRNA and protein expression in DRG neurons and spinal cord in a spinal nerve ligation neuropathic pain model. miR-30b agomir transfection down-regulated Nav1.3 stimulated by TNF-α in primary DRG neurons; miR-30b antagomir activated Nav1.3 expression.","method":"miR-30b agomir/antagomir transfection in primary DRG neurons; in vivo SNL model with intrathecal miR-30b delivery; western blot and qRT-PCR for Nav1.3; behavioral pain assays","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional miRNA manipulation (agomir and antagomir) in vitro and in vivo, single lab","pmids":["28529474"],"is_preprint":false},{"year":2018,"finding":"De novo pathogenic Nav1.3 variants (p.Ile875Thr, p.Pro1333Leu, p.Val1769Ala) associated with infantile epileptic encephalopathy showed prominent gain of channel function with markedly increased slowly inactivating persistent current and, for two variants, leftward shift in voltage dependence of activation. Antiseizure drugs phenytoin and lacosamide selectively blocked slowly inactivating over transient current in both wild-type and mutant Nav1.3.","method":"Whole-cell patch clamp electrophysiology of heterologously expressed mutant Nav1.3; pharmacological testing with phenytoin and lacosamide","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct mutagenesis and electrophysiology in native Nav1.3, multiple variants, pharmacological characterization, single rigorous study","pmids":["29466837"],"is_preprint":false},{"year":2018,"finding":"Pathogenic Nav1.3 variants causing polymicrogyria of the perisylvian cortex exhibited increased persistent current in heterologous expression. SCN3A expression is highest in fetal cortical progenitor cells of the outer subventricular zone and cortical plate neurons and decreases postnatally. Expression of a mutant Nav1.3 channel in ferrets recapitulated disrupted cortical folding and neuronal migration, establishing a developmental role for Nav1.3 in progenitor cells and migrating neurons.","method":"Whole-cell patch clamp of mutant Nav1.3 in heterologous cells; immunostaining and in situ hybridization of human fetal cortex; in utero ferret electroporation of mutant channel; cortical histology","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1 / Strong — electrophysiology + human tissue expression + in vivo animal model, multiple orthogonal methods, single rigorous study","pmids":["30146301"],"is_preprint":false},{"year":2018,"finding":"Nav1.3 is expressed in neutrophils recruited to ischemic mouse heart and kidney in vivo. Nav1.3-preferring inhibitors (ICA121431, Pterinotoxin-2) reduced endothelial adhesion, transmigration through endothelium, and chemotaxis of neutrophils in vitro, placing Nav1.3 as a regulator of neutrophil extravasation.","method":"PCR and flow cytometry of neutrophil Nav1.3 expression; mouse ischemia models; inhibitor treatment (TTX, ICA121431, Pterinotoxin-2, lidocaine); in vitro adhesion, transmigration, chemotaxis assays; whole-cell patch clamp of sodium currents","journal":"Anesthesiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays with selective inhibitors plus patch clamp, single lab","pmids":["29509584"],"is_preprint":false},{"year":2018,"finding":"Extracellular acidosis produces a depolarizing shift in the voltage dependence of activation and moderate reduction in current density of Nav1.3, while voltage dependence of steady-state fast inactivation and recovery from fast inactivation are unchanged.","method":"Whole-cell patch clamp electrophysiology of Nav1.3 at varying extracellular pH","journal":"Channels (Austin, Tex.)","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct electrophysiological characterization, single lab, single method","pmids":["30362397"],"is_preprint":false},{"year":2020,"finding":"Among 22 patients with pathogenic SCN3A variants, 10 of 11 tested pathogenic missense variants displayed gain of channel function (increased persistent current and/or leftward shift in voltage dependence of activation) when coexpressed with β1 and β2 subunits in HEK-293T cells. All variants associated with malformation of cortical development showed gain of function; variants clustering in transmembrane segments 4–6 of domains II–IV were most pathogenic.","method":"Whole-cell voltage clamp in HEK-293T cells coexpressing Nav1.3 with β1 and β2 subunits; systematic analysis of 11 pathogenic variants; patient cohort genotyping","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic electrophysiological characterization of 11 variants in native Nav1.3 with β subunits, large patient cohort, single rigorous multicenter study","pmids":["32515017"],"is_preprint":false},{"year":2020,"finding":"miR-384-5p directly targets SCN3A as validated by dual-luciferase reporter assay. miR-384-5p agomir decreased Nav1.3 expression and alleviated mechanical allodynia and heat hyperalgesia in CCI rats.","method":"Dual-luciferase reporter assay; miR-384-5p agomir delivery in CCI rat model; western blot and qPCR for Nav1.3; behavioral pain assays","journal":"Neurological research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase validation plus in vivo knockdown with functional readout, single lab","pmids":["32098588"],"is_preprint":false},{"year":2021,"finding":"miR-214-3p targets Nav1.3 and TLR4 as validated by dual-luciferase reporter assay. Overexpression of miR-214-3p in STZ-induced diabetic neuropathy rats reduced Nav1.3 expression, reversed thermal hyperalgesia, and improved nerve conduction velocity.","method":"Dual-luciferase reporter assay; lentiviral miR-214-3p delivery; western blot; neurophysiological measurements; behavioral assays","journal":"Cell biology international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase target validation plus in vivo functional readout, single lab","pmids":["34296787"],"is_preprint":false},{"year":2024,"finding":"SIRT1 epigenetically regulates Nav1.3 in spinal CaMKIIα+ neurons: knockdown of spinal SIRT1 increased acetylation of histone H3 at the Scn3a promoter, increasing Nav1.3 expression and activating CaMKIIα+ neurons to cause neuropathic pain. Overexpression of SIRT1 reversed Nav1.3 upregulation and alleviated pain after CCI.","method":"ChIP-PCR for histone H3 acetylation at Scn3a promoter; co-immunoprecipitation; SIRT1 knockout (Sirt1loxP/loxP) and overexpression; chemogenetic activation/inhibition of CaMKIIα+ neurons; transcriptome sequencing; western blot; qRT-PCR; behavioral pain assays","journal":"CNS neuroscience & therapeutics","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-PCR of specific promoter region + genetic KO + overexpression + co-IP, multiple orthogonal methods in single study","pmids":["38828629"],"is_preprint":false},{"year":2024,"finding":"SCN3A-p.Ile875Thr iPSC-derived glutamatergic neurons (iNeurons) exhibit markedly increased slowly inactivating/persistent Na+ current, abnormal firing with paroxysmal bursting and plateau potentials, and a hyperpolarized voltage threshold for action potential generation compared to isogenic controls. The Nav1.3-selective blocker ICA-121431 normalized action potential threshold and aberrant firing in variant iNeurons, validating Nav1.3 as the mediator of pathological hyperexcitability.","method":"CRISPR/Cas9 gene editing of iPSCs; Ngn2-directed differentiation to iNeurons; whole-cell patch clamp electrophysiology; pharmacological blockade with ICA-121431; patient-derived iPSC isogenic control comparison","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 1 / Strong — CRISPR-engineered isogenic human neurons plus patient-derived iPSC line, direct electrophysiology, pharmacological rescue, multiple orthogonal validations","pmids":["37935051"],"is_preprint":false},{"year":2025,"finding":"Three novel SCN3A variants (p.L209P, p.N52H, p.E1809K) show distinct biophysical mechanisms: p.N52H reduced current density and hyperpolarized activation (mixed gain- and loss-of-function); p.L209P selectively hyperpolarized activation curve; p.E1809K altered fast inactivation and accelerated recovery kinetics. All were expressed in CHO cells with β1 subunits.","method":"Whole-cell patch clamp electrophysiology in CHO cells cotransfected with mutant Nav1.3 and β1 subunits; whole-exome sequencing; clinical phenotyping","journal":"Channels (Austin, Tex.)","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct electrophysiological characterization with mutagenesis, single lab, single study","pmids":["41165134"],"is_preprint":false}],"current_model":"Nav1.3 (SCN3A) is a voltage-gated sodium channel α-subunit that generates rapidly activating, fast-inactivating, rapidly repriming TTX-sensitive Na+ currents with slow closed-state inactivation; its cell-surface expression is increased by the adhesion molecule contactin and its gating is modulated by β1/β3 auxiliary subunits (which slow repriming and shift inactivation) and by calmodulin binding to its C-terminus; in the developing brain Nav1.3 is highly expressed in progenitor cells and migrating cortical neurons where gain-of-function mutations cause polymicrogyria and epileptic encephalopathy through increased persistent current; after peripheral or central nerve injury, TNF-α acting via NF-κB and p38 MAPK/JNK signaling drives Nav1.3 re-expression in sensory and spinal neurons, and in the spinal dorsal horn SIRT1 loss leads to histone H3 acetylation at the Scn3a promoter and Nav1.3 upregulation—collectively producing neuronal hyperexcitability and neuropathic pain; Nav1.3 is also functionally expressed in pancreatic α-cells (where it is required for glucagon secretion) and neutrophils (where it regulates adhesion and transmigration)."},"narrative":{"mechanistic_narrative":"SCN3A encodes Nav1.3, a voltage-gated sodium channel α-subunit that generates rapidly activating, fast-inactivating currents with rapid repriming at negative potentials, slow closed-state inactivation, and large ramp currents in response to slow depolarizations [PMID:11487618, PMID:12220575]. Channel behavior is shaped by auxiliary β-subunits: β1 and β3 shift steady-state inactivation negatively and slow repriming, with the β3 intracellular domain (a short amphipathic α-helix plus a disordered region) stabilizing fast inactivation, whereas β2 has little effect [PMID:12220575, PMID:20675377]. Cell-surface current is amplified by the adhesion molecule contactin, which binds the Nav1.3 N- and C-termini and increases functional channel density at the membrane without altering biophysical properties [PMID:15317864], and channel gating is further modulated by calmodulin binding to the C-terminus and by PKC phosphorylation [PMID:16912065, PMID:21314936]. Nav1.3 plays a central developmental role: it is most highly expressed in fetal cortical progenitors and migrating cortical neurons, and gain-of-function variants that increase persistent and ramp current cause polymicrogyria and infantile epileptic encephalopathy, with the most pathogenic variants clustering in transmembrane segments 4–6 of domains II–IV [PMID:29466837, PMID:30146301, PMID:32515017]. This gain-of-function mechanism produces neuronal hyperexcitability that has been recapitulated in patient-derived and isogenic iPSC neurons and reversed by the Nav1.3-selective blocker ICA-121431 [PMID:37935051]. After nerve or spinal cord injury Nav1.3 is re-expressed in sensory and dorsal horn/thalamic neurons, driving hyperexcitability and neuropathic pain; this re-expression is driven by TNF-α signaling through NF-κB and p38 MAPK/JNK and is controlled epigenetically, including by SIRT1-dependent histone H3 acetylation at the Scn3a promoter [PMID:14523090, PMID:16109750, PMID:20638792, PMID:20858468, PMID:22129822, PMID:38828629]. Beyond the nervous system, Nav1.3 is the predominant sodium channel α-subunit in pancreatic α-cells where it is required for glucagon and insulin secretion, and it regulates neutrophil adhesion and transmigration [PMID:25172946, PMID:29509584].","teleology":[{"year":2001,"claim":"Established the intrinsic biophysical signature of Nav1.3 — fast activation/inactivation, rapid repriming, slow closed-state inactivation and large ramp currents — and showed cellular background modulates these properties, defining the channel's baseline behavior.","evidence":"Whole-cell patch clamp of TTX-resistant Nav1.3 in HEK293 and SNS-null DRG neurons with β-subunit coexpression","pmids":["11487618"],"confidence":"High","gaps":["β-subunit effects were small in this system","structural basis of slow closed-state inactivation not addressed"]},{"year":2002,"claim":"Confirmed and quantified that β1 and β3, but not β2, modulate Nav1.3 inactivation voltage dependence and repriming, defining which auxiliary subunits shape channel kinetics.","evidence":"Whole-cell patch clamp in stably transfected CHO cells with β1/β2/β3 coexpression","pmids":["12220575"],"confidence":"High","gaps":["did not resolve structural mechanism of β-subunit action","native neuronal β-subunit composition not determined"]},{"year":2003,"claim":"Linked Nav1.3 upregulation in second-order dorsal horn neurons to central neuropathic pain, moving the channel from a biophysical entity to a disease driver after spinal cord injury.","evidence":"Intrathecal antisense ODN knockdown with electrophysiological, molecular and behavioral readouts plus reversal controls in rat SCI model","pmids":["14523090"],"confidence":"High","gaps":["upstream signal driving Nav1.3 upregulation not identified","antisense specificity limits"]},{"year":2004,"claim":"Identified contactin as a Nav1.3 interactor that increases surface channel density, providing a mechanism for regulating functional channel abundance distinct from gating modulation.","evidence":"Reciprocal Co-IP from rat brain and HEK293 cells, GST pulldown of N/C termini, patch clamp, and enzymatic surface removal","pmids":["15317864"],"confidence":"High","gaps":["intracellular trafficking pathway not mapped","physiological role of contactin–Nav1.3 in vivo not tested"]},{"year":2005,"claim":"Extended injury-driven Nav1.3 pathology to thalamic relay neurons, showing the channel alters supraspinal somatosensory processing after SCI.","evidence":"Antisense ODN knockdown with thalamic unit recordings and anatomical controls in rat SCI model","pmids":["16109750"],"confidence":"High","gaps":["mechanism of remote thalamic upregulation unresolved","no direct human correlate"]},{"year":2006,"claim":"Demonstrated calmodulin binds the Nav1.3 C-terminus and modulates current and Ca2+-dependent activation, adding a calcium-sensing layer to channel regulation.","evidence":"GST C-terminal pulldown, Co-IP, and patch clamp with CaM inhibitors and Ca2+ manipulation in vasa recta pericytes","pmids":["16912065"],"confidence":"Medium","gaps":["single lab, peripheral cell type","structural CaM-binding determinants not mapped"]},{"year":2010,"claim":"Established the canonical gain-of-function disease mechanism by showing an epilepsy-linked variant (K354Q) enhances persistent and ramp currents in native Nav1.3 and induces spontaneous neuronal firing.","evidence":"Site-directed mutagenesis with patch clamp in HEK293 cells and hippocampal neurons","pmids":["20420834"],"confidence":"High","gaps":["genotype–phenotype generalization beyond one variant not yet established","in vivo consequence not tested"]},{"year":2010,"claim":"Defined the inflammatory upstream pathway for injury-induced Nav1.3 re-expression, placing TNF-α (via TNFR1) and NF-κB as drivers in sensory neurons.","evidence":"In vivo/in vitro recombinant TNF-α, TNFR1 knockout mice, NF-κB inhibitor PDTC, with molecular and electrophysiological readouts","pmids":["20638792","20858468"],"confidence":"High","gaps":["direct transcription factor binding to Scn3a promoter not shown","NF-κB epistasis was pharmacological"]},{"year":2010,"claim":"Resolved the structural basis of β3-mediated gating control, showing its amphipathic helix and disordered region stabilize fast inactivation of Nav1.3.","evidence":"Patch clamp plus CD/NMR of β3 intracellular domain and deletion mutagenesis in HEK293 cells","pmids":["20675377"],"confidence":"High","gaps":["full channel–β3 complex structure not determined","in vivo relevance of biphasic inactivation unclear"]},{"year":2011,"claim":"Added kinase regulation (p38 MAPK/JNK downstream of TNF-α; PKC modulation of gating) to the network controlling Nav1.3 expression and function in neuropathic states.","evidence":"Pharmacological kinase inhibition in cultured DRG neurons and PKC inhibitors in stable CHO Nav1.3 cells with patch clamp","pmids":["22129822","21314936"],"confidence":"Medium","gaps":["direct phosphorylation sites on Nav1.3 not mapped","pharmacological inhibitor specificity"]},{"year":2013,"claim":"Generalized the gain-of-function model by showing a panel of SCN3A epilepsy variants share increased ramp-current activation despite heterogeneous individual defects.","evidence":"Site-directed mutagenesis and patch clamp of multiple human Nav1.3 variants in HEK293/CHO cells","pmids":["24157691"],"confidence":"High","gaps":["mechanistic basis for shared ramp current not resolved","no in vivo modeling of these variants"]},{"year":2014,"claim":"Revealed multilayered post-transcriptional and epigenetic control of Scn3a — CpG methylation/MBD2, GAPDH binding to the 3'UTR, and microRNA targeting — establishing how channel abundance is tuned in seizure and pain states.","evidence":"Reporter assays, MBD2/GAPDH knockdown, RNA-protein binding, mRNA stability assays, and miRNA delivery across seizure and CCI models","pmids":["25459751","27816501","24234845"],"confidence":"Medium","gaps":["relative contribution of each regulatory layer in vivo unclear","single-lab findings for individual mechanisms"]},{"year":2014,"claim":"Identified a non-neuronal physiological role: Nav1.3 is the dominant α-cell sodium channel and is required for islet glucagon and insulin secretion.","evidence":"Single-cell PCR, Scn3a knockout mice, patch clamp of α/β cells, and hormone secretion assays","pmids":["25172946"],"confidence":"High","gaps":["coupling between Nav1.3 current and secretory machinery not detailed","human islet relevance not addressed"]},{"year":2016,"claim":"Showed that loss-of-function Nav1.3 (trafficking-deficient L247P; hypomorphic mice) can also increase seizure susceptibility, revealing that both gain and loss of channel activity disrupt network excitability.","evidence":"Heterologous expression, surface biotinylation, and Scn3a hypomorphic mouse seizure-threshold and behavioral testing","pmids":["28235671"],"confidence":"High","gaps":["mechanism reconciling gain- and loss-of-function phenotypes unresolved","trafficking defect not localized to a specific step"]},{"year":2018,"claim":"Established Nav1.3 as a developmental channel whose persistent-current gain-of-function variants cause polymicrogyria by disrupting cortical neuronal migration and folding.","evidence":"Patch clamp of variants, human fetal cortex expression mapping, and in utero ferret electroporation recapitulating cortical malformation","pmids":["30146301","29466837"],"confidence":"High","gaps":["how sodium current influences migration mechanistically not defined","progenitor-cell function of the channel unresolved"]},{"year":2018,"claim":"Extended Nav1.3 function to innate immunity, implicating it in neutrophil adhesion, transmigration and chemotaxis during ischemic injury.","evidence":"Neutrophil expression profiling, mouse ischemia models, selective inhibitors, and in vitro migration assays with patch clamp","pmids":["29509584"],"confidence":"Medium","gaps":["downstream signaling linking Nav1.3 to motility unknown","inhibitor selectivity caveats"]},{"year":2020,"claim":"Systematized genotype–phenotype correlation by showing nearly all cortical-malformation–associated variants are gain-of-function and localize to domain II–IV S4–S6 segments.","evidence":"Whole-cell voltage clamp of 11 variants coexpressed with β1/β2 in HEK-293T cells across a 22-patient cohort","pmids":["32515017"],"confidence":"High","gaps":["mechanistic link between channel locus and phenotype severity not fully explained","loss-of-function variants underrepresented"]},{"year":2024,"claim":"Provided human-cell validation that a recurrent variant drives pathological hyperexcitability via persistent current, with pharmacological rescue confirming Nav1.3 causality.","evidence":"CRISPR isogenic and patient-derived iPSC glutamatergic neurons, patch clamp, and ICA-121431 rescue","pmids":["37935051"],"confidence":"High","gaps":["network/circuit-level consequences in human tissue not tested","single variant studied"]},{"year":2024,"claim":"Identified a specific epigenetic switch (SIRT1-dependent histone H3 acetylation at the Scn3a promoter) controlling injury-induced Nav1.3 upregulation in defined spinal neuron populations.","evidence":"ChIP-PCR, SIRT1 knockout/overexpression, Co-IP, chemogenetics in CaMKIIα+ neurons, and behavioral pain assays in CCI model","pmids":["38828629"],"confidence":"High","gaps":["direct SIRT1 substrate at the promoter not defined","integration with TNF-α/NF-κB axis not tested"]},{"year":null,"claim":"It remains unresolved how the same channel produces opposing gain- and loss-of-function disease phenotypes and how Nav1.3 sodium influx mechanistically controls non-electrical processes such as cortical progenitor behavior, neutrophil migration, and islet hormone secretion.","evidence":"","pmids":[],"confidence":"High","gaps":["no unifying mechanism for gain- vs loss-of-function epilepsy outcomes","molecular coupling of Na+ current to migration/secretion/motility undefined","no high-resolution structure of Nav1.3 with auxiliary partners in the timeline"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,16]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,24,32]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,21]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,25,32]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[25]}],"complexes":[],"partners":["CNTN1","SCN1B","SCN3B","CALM1","SCN2B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NY46","full_name":"Sodium channel protein type 3 subunit alpha","aliases":["Sodium channel protein brain III subunit alpha","Sodium channel protein type III subunit alpha","Voltage-gated sodium channel subtype III","Voltage-gated sodium channel subunit alpha Nav1.3"],"length_aa":2000,"mass_kda":226.3,"function":"Pore-forming subunit of Nav1.3, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provokes membrane depolarization, initiating the propagation of electrical signals throughout cells and tissues (PubMed:24157691, PubMed:28235671, PubMed:29466837, PubMed:35277491). In some secretory cell types, it also participates in cell excitability through membrane depolarization and regulates cells responsiveness to stimuli triggering secretion. For instance, it controls the release of serotonin/5-hydroxytryptamine by enterochromaffin cells and is required for both glucagon- and glucose-induced insulin secretion in pancreatic endocrine cells (By similarity)","subcellular_location":"Cell membrane; Basal cell membrane","url":"https://www.uniprot.org/uniprotkb/Q9NY46/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SCN3A","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SCN3A","total_profiled":1310},"omim":[{"mim_id":"617938","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 62; DEE62","url":"https://www.omim.org/entry/617938"},{"mim_id":"617935","title":"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4","url":"https://www.omim.org/entry/617935"},{"mim_id":"617350","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52; DEE52","url":"https://www.omim.org/entry/617350"},{"mim_id":"608325","title":"PHD FINGER PROTEIN 21A; PHF21A","url":"https://www.omim.org/entry/608325"},{"mim_id":"604364","title":"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1; FFEVF1","url":"https://www.omim.org/entry/604364"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":8.6},{"tissue":"lymphoid tissue","ntpm":3.7}],"url":"https://www.proteinatlas.org/search/SCN3A"},"hgnc":{"alias_symbol":["Nav1.3"],"prev_symbol":[]},"alphafold":{"accession":"Q9NY46","domains":[{"cath_id":"-","chopping":"20-35_52-207","consensus_level":"medium","plddt":80.4062,"start":20,"end":207},{"cath_id":"1.20.120.350","chopping":"738-865","consensus_level":"high","plddt":82.5952,"start":738,"end":865},{"cath_id":"1.20.120.350","chopping":"1207-1318","consensus_level":"high","plddt":85.2534,"start":1207,"end":1318},{"cath_id":"1.20.120.350","chopping":"1515-1638","consensus_level":"high","plddt":81.8535,"start":1515,"end":1638},{"cath_id":"1.10.238.10","chopping":"1788-1881_1889-1915","consensus_level":"medium","plddt":77.2522,"start":1788,"end":1915}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NY46","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NY46-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NY46-F1-predicted_aligned_error_v6.png","plddt_mean":68.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SCN3A","jax_strain_url":"https://www.jax.org/strain/search?query=SCN3A"},"sequence":{"accession":"Q9NY46","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NY46.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NY46/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NY46"}},"corpus_meta":[{"pmid":"14523090","id":"PMC_14523090","title":"Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14523090","citation_count":280,"is_preprint":false},{"pmid":"11487618","id":"PMC_11487618","title":"Nav1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11487618","citation_count":249,"is_preprint":false},{"pmid":"12610651","id":"PMC_12610651","title":"Sodium channels SCN1A, SCN2A and SCN3A in familial autism.","date":"2003","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12610651","citation_count":229,"is_preprint":false},{"pmid":"20638792","id":"PMC_20638792","title":"TNF-α contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury.","date":"2010","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/20638792","citation_count":151,"is_preprint":false},{"pmid":"16109750","id":"PMC_16109750","title":"Changes in electrophysiological properties and sodium channel Nav1.3 expression in thalamic neurons after spinal cord injury.","date":"2005","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16109750","citation_count":147,"is_preprint":false},{"pmid":"16061326","id":"PMC_16061326","title":"Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats.","date":"2005","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/16061326","citation_count":143,"is_preprint":false},{"pmid":"17052333","id":"PMC_17052333","title":"Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice.","date":"2006","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/17052333","citation_count":134,"is_preprint":false},{"pmid":"18242854","id":"PMC_18242854","title":"Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy.","date":"2008","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18242854","citation_count":122,"is_preprint":false},{"pmid":"30146301","id":"PMC_30146301","title":"Sodium Channel SCN3A (NaV1.3) Regulation of Human Cerebral Cortical Folding and Oral Motor Development.","date":"2018","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/30146301","citation_count":121,"is_preprint":false},{"pmid":"24234845","id":"PMC_24234845","title":"Intrathecal miR-96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury.","date":"2014","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/24234845","citation_count":106,"is_preprint":false},{"pmid":"19699781","id":"PMC_19699781","title":"Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia.","date":"2009","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19699781","citation_count":102,"is_preprint":false},{"pmid":"29466837","id":"PMC_29466837","title":"Mutations in SCN3A cause early infantile epileptic encephalopathy.","date":"2018","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29466837","citation_count":83,"is_preprint":false},{"pmid":"20420834","id":"PMC_20420834","title":"A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons.","date":"2010","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20420834","citation_count":81,"is_preprint":false},{"pmid":"18784617","id":"PMC_18784617","title":"Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.","date":"2008","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18784617","citation_count":80,"is_preprint":false},{"pmid":"28529474","id":"PMC_28529474","title":"MiR-30b Attenuates Neuropathic Pain by Regulating Voltage-Gated Sodium Channel Nav1.3 in Rats.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28529474","citation_count":78,"is_preprint":false},{"pmid":"25172946","id":"PMC_25172946","title":"Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression.","date":"2014","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25172946","citation_count":77,"is_preprint":false},{"pmid":"12220575","id":"PMC_12220575","title":"Functional modulation of human brain Nav1.3 sodium channels, expressed in mammalian cells, by auxiliary beta 1, beta 2 and beta 3 subunits.","date":"2002","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12220575","citation_count":76,"is_preprint":false},{"pmid":"24157691","id":"PMC_24157691","title":"Novel SCN3A variants associated with focal epilepsy in children.","date":"2013","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/24157691","citation_count":75,"is_preprint":false},{"pmid":"32515017","id":"PMC_32515017","title":"SCN3A-Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain Malformation.","date":"2020","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32515017","citation_count":65,"is_preprint":false},{"pmid":"26101954","id":"PMC_26101954","title":"Virus-Mediated Knockdown of Nav1.3 in Dorsal Root Ganglia of STZ-Induced Diabetic Rats Alleviates Tactile Allodynia.","date":"2015","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/26101954","citation_count":62,"is_preprint":false},{"pmid":"28235671","id":"PMC_28235671","title":"SCN3A deficiency associated with increased seizure susceptibility.","date":"2017","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/28235671","citation_count":57,"is_preprint":false},{"pmid":"23859570","id":"PMC_23859570","title":"SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.","date":"2013","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/23859570","citation_count":52,"is_preprint":false},{"pmid":"15317864","id":"PMC_15317864","title":"Contactin associates with sodium channel Nav1.3 in native tissues and increases channel density at the cell surface.","date":"2004","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15317864","citation_count":48,"is_preprint":false},{"pmid":"27327156","id":"PMC_27327156","title":"Changes in the expression of voltage-gated sodium channels Nav1.3, Nav1.7, Nav1.8, and Nav1.9 in rat trigeminal ganglia following chronic constriction injury.","date":"2016","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/27327156","citation_count":46,"is_preprint":false},{"pmid":"20858468","id":"PMC_20858468","title":"Inhibition of NF-kappaB prevents mechanical allodynia induced by spinal ventral root transection and suppresses the re-expression of Nav1.3 in DRG neurons in vivo and in vitro.","date":"2010","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/20858468","citation_count":45,"is_preprint":false},{"pmid":"27013471","id":"PMC_27013471","title":"Epigenetic Downregulation of Scn3a Expression by Valproate: a Possible Role in Its Anticonvulsant Activity.","date":"2016","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27013471","citation_count":44,"is_preprint":false},{"pmid":"18158113","id":"PMC_18158113","title":"Voltage-gated sodium channel Nav1.1, Nav1.3 and beta1 subunit were up-regulated in the hippocampus of spontaneously epileptic rat.","date":"2007","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/18158113","citation_count":42,"is_preprint":false},{"pmid":"11245985","id":"PMC_11245985","title":"Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11245985","citation_count":36,"is_preprint":false},{"pmid":"28298073","id":"PMC_28298073","title":"Electro-acupuncture-modulated miR-214 prevents neuronal apoptosis by targeting Bax and inhibits sodium channel Nav1.3 expression in rats after spinal cord injury.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28298073","citation_count":36,"is_preprint":false},{"pmid":"12941467","id":"PMC_12941467","title":"L-type calcium channel activation up-regulates the mRNAs for two different sodium channel alpha subunits (Nav1.2 and Nav1.3) in rat pituitary GH3 cells.","date":"2003","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12941467","citation_count":35,"is_preprint":false},{"pmid":"20675377","id":"PMC_20675377","title":"The sodium channel {beta}3-subunit induces multiphasic gating in NaV1.3 and affects fast inactivation via distinct intracellular regions.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20675377","citation_count":34,"is_preprint":false},{"pmid":"30993766","id":"PMC_30993766","title":"Long noncoding RNA HOXA-AS2 regulates the expression of SCN3A by sponging miR-106a in breast cancer.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30993766","citation_count":33,"is_preprint":false},{"pmid":"8159690","id":"PMC_8159690","title":"Targeted gene walking by low stringency polymerase chain reaction: assignment of a putative human brain sodium channel gene (SCN3A) to chromosome 2q24-31.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8159690","citation_count":32,"is_preprint":false},{"pmid":"24337656","id":"PMC_24337656","title":"Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy.","date":"2013","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24337656","citation_count":31,"is_preprint":false},{"pmid":"12706451","id":"PMC_12706451","title":"Lidocaine block of neonatal Nav1.3 is differentially modulated by co-expression of beta1 and beta3 subunits.","date":"2003","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12706451","citation_count":30,"is_preprint":false},{"pmid":"24990319","id":"PMC_24990319","title":"Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A.","date":"2014","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24990319","citation_count":26,"is_preprint":false},{"pmid":"17544618","id":"PMC_17544618","title":"Characterization of 5' untranslated regions of the voltage-gated sodium channels SCN1A, SCN2A, and SCN3A and identification of cis-conserved noncoding sequences.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17544618","citation_count":25,"is_preprint":false},{"pmid":"32098588","id":"PMC_32098588","title":"miR-384-5p ameliorates neuropathic pain by targeting SCN3A in a rat model of chronic constriction injury.","date":"2020","source":"Neurological research","url":"https://pubmed.ncbi.nlm.nih.gov/32098588","citation_count":25,"is_preprint":false},{"pmid":"29783906","id":"PMC_29783906","title":"Bulleyaconitine A attenuates hyperexcitability of dorsal root ganglion neurons induced by spared nerve injury: The role of preferably blocking Nav1.7 and Nav1.3 channels.","date":"2018","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/29783906","citation_count":25,"is_preprint":false},{"pmid":"21676267","id":"PMC_21676267","title":"Intrathecal lidocaine pretreatment attenuates immediate neuropathic pain by modulating Nav1.3 expression and decreasing spinal microglial activation.","date":"2011","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21676267","citation_count":23,"is_preprint":false},{"pmid":"25459751","id":"PMC_25459751","title":"Alteration of Scn3a expression is mediated via CpG methylation and MBD2 in mouse hippocampus during postnatal development and seizure condition.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25459751","citation_count":22,"is_preprint":false},{"pmid":"21314936","id":"PMC_21314936","title":"Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase C.","date":"2011","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/21314936","citation_count":21,"is_preprint":false},{"pmid":"30362397","id":"PMC_30362397","title":"Effects of acidosis on neuronal voltage-gated sodium channels: Nav1.1 and Nav1.3.","date":"2018","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/30362397","citation_count":20,"is_preprint":false},{"pmid":"34296787","id":"PMC_34296787","title":"MiR-214-3p plays a protective role in diabetic neuropathic rats by regulating Nav1.3 and TLR4.","date":"2021","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/34296787","citation_count":20,"is_preprint":false},{"pmid":"21893419","id":"PMC_21893419","title":"Infantile epilepsy associated with mosaic 2q24 duplication including SCN2A and SCN3A.","date":"2011","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/21893419","citation_count":20,"is_preprint":false},{"pmid":"16912065","id":"PMC_16912065","title":"Vasa recta voltage-gated Na+ channel Nav1.3 is regulated by calmodulin.","date":"2006","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16912065","citation_count":19,"is_preprint":false},{"pmid":"22928478","id":"PMC_22928478","title":"Expression of voltage-gated sodium channel Nav1.3 is associated with severity of traumatic brain injury in adult rats.","date":"2012","source":"Journal of neurotrauma","url":"https://pubmed.ncbi.nlm.nih.gov/22928478","citation_count":18,"is_preprint":false},{"pmid":"35332400","id":"PMC_35332400","title":"Structure and Function of Sodium Channel Nav1.3 in Neurological Disorders.","date":"2022","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/35332400","citation_count":17,"is_preprint":false},{"pmid":"31677917","id":"PMC_31677917","title":"Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants: two new cases and review of the literature.","date":"2019","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/31677917","citation_count":16,"is_preprint":false},{"pmid":"29509584","id":"PMC_29509584","title":"Sodium Channel Nav1.3 Is Expressed by Polymorphonuclear Neutrophils during Mouse Heart and Kidney Ischemia In Vivo and Regulates Adhesion, Transmigration, and Chemotaxis of Human and Mouse Neutrophils In Vitro.","date":"2018","source":"Anesthesiology","url":"https://pubmed.ncbi.nlm.nih.gov/29509584","citation_count":16,"is_preprint":false},{"pmid":"22129822","id":"PMC_22129822","title":"Upregulation of Nav1.3 Channel Induced by rrTNF in Cultured Adult Rat DRG Neurons via p38 MAPK and JNK Pathways.","date":"2011","source":"The Chinese journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22129822","citation_count":16,"is_preprint":false},{"pmid":"8812438","id":"PMC_8812438","title":"A new sodium channel alpha-subunit gene (Scn9a) from Schwann cells maps to the Scn1a, Scn2a, Scn3a cluster of mouse chromosome 2.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8812438","citation_count":14,"is_preprint":false},{"pmid":"24313291","id":"PMC_24313291","title":"Blockage of the upregulation of voltage-gated sodium channel nav1.3 improves outcomes after experimental traumatic brain injury.","date":"2013","source":"Journal of neurotrauma","url":"https://pubmed.ncbi.nlm.nih.gov/24313291","citation_count":14,"is_preprint":false},{"pmid":"27153334","id":"PMC_27153334","title":"Whole gene duplication of SCN2A and SCN3A is associated with neonatal seizures and a normal intellectual development.","date":"2016","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27153334","citation_count":13,"is_preprint":false},{"pmid":"29689688","id":"PMC_29689688","title":"Swimming Exercise Induced Reversed Expression of miR-96 and Its Target Gene NaV1.3 in Diabetic Peripheral Neuropathy in Rats.","date":"2018","source":"The Chinese journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29689688","citation_count":13,"is_preprint":false},{"pmid":"22622820","id":"PMC_22622820","title":"Pharmacological kinetics of BmK AS, a sodium channel site 4-specific modulator on Nav1.3.","date":"2012","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/22622820","citation_count":13,"is_preprint":false},{"pmid":"27816501","id":"PMC_27816501","title":"GAPDH-mediated posttranscriptional regulations of sodium channel Scn1a and Scn3a genes under seizure and ketogenic diet conditions.","date":"2016","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27816501","citation_count":12,"is_preprint":false},{"pmid":"38828629","id":"PMC_38828629","title":"SIRT1 mediates the excitability of spinal CaMKIIα-positive neurons and participates in neuropathic pain by controlling Nav1.3.","date":"2024","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/38828629","citation_count":12,"is_preprint":false},{"pmid":"24080482","id":"PMC_24080482","title":"Interstitial 2q24.3 deletion including SCN2A and SCN3A genes in a patient with autistic features, psychomotor delay, microcephaly and no history of seizures.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24080482","citation_count":12,"is_preprint":false},{"pmid":"33895391","id":"PMC_33895391","title":"Mutations in the sodium channel genes SCN1A, SCN3A, and SCN9A in children with epilepsy with febrile seizures plus(EFS+).","date":"2021","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/33895391","citation_count":12,"is_preprint":false},{"pmid":"29929112","id":"PMC_29929112","title":"Deletions of SCN2A and SCN3A genes in a patient with West syndrome and autistic spectrum disorder.","date":"2018","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/29929112","citation_count":11,"is_preprint":false},{"pmid":"37935051","id":"PMC_37935051","title":"Targeted blockade of aberrant sodium current in a stem cell-derived neuron model of SCN3A encephalopathy.","date":"2024","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37935051","citation_count":10,"is_preprint":false},{"pmid":"27072680","id":"PMC_27072680","title":"Mutant SOD1 protein increases Nav1.3 channel excitability.","date":"2016","source":"Journal of biological physics","url":"https://pubmed.ncbi.nlm.nih.gov/27072680","citation_count":10,"is_preprint":false},{"pmid":"22494998","id":"PMC_22494998","title":"Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb.","date":"2012","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/22494998","citation_count":10,"is_preprint":false},{"pmid":"34726508","id":"PMC_34726508","title":"Knockdown of rno_circRNA_009194 Improves Outcomes in Traumatic Brain Injury Rats through Inhibiting Voltage-Gated Sodium Channel Nav1.3.","date":"2021","source":"Journal of neurotrauma","url":"https://pubmed.ncbi.nlm.nih.gov/34726508","citation_count":10,"is_preprint":false},{"pmid":"21271300","id":"PMC_21271300","title":"Promoter analysis of mouse Scn3a gene and regulation of the promoter activity by GC box and CpG methylation.","date":"2011","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/21271300","citation_count":9,"is_preprint":false},{"pmid":"33881614","id":"PMC_33881614","title":"Slow recovery from the inactivation of voltage-gated sodium channel Nav1.3 in mouse taste receptor cells.","date":"2021","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33881614","citation_count":9,"is_preprint":false},{"pmid":"38714229","id":"PMC_38714229","title":"Exploring the mechanism of Nav1.3 in the ION-CCI rat model based on the TLR4/TRAF6/NF-κB pathway.","date":"2024","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/38714229","citation_count":6,"is_preprint":false},{"pmid":"30267849","id":"PMC_30267849","title":"Re-expression of voltage-gated sodium channel subtype Nav1.3 in the substantia nigra after dopamine depletion.","date":"2018","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/30267849","citation_count":5,"is_preprint":false},{"pmid":"27690330","id":"PMC_27690330","title":"Mapping of a FEB3 homologous febrile seizure locus on mouse chromosome 2 containing candidate genes Scn1a and Scn3a.","date":"2016","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27690330","citation_count":3,"is_preprint":false},{"pmid":"34102392","id":"PMC_34102392","title":"Identification of a novel variant p.Ser606Gly in SCN3A associated with childhood absence epilepsy.","date":"2021","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/34102392","citation_count":2,"is_preprint":false},{"pmid":"41165134","id":"PMC_41165134","title":"SCN3A-related neurodevelopmental disorder: Clinical case reports and biophysical characterization.","date":"2025","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/41165134","citation_count":1,"is_preprint":false},{"pmid":"40180210","id":"PMC_40180210","title":"MiR-30b-5p alleviates trigeminal neuralgia induced by chronic constriction injury of the infraorbital nerve by regulating the voltage-gated sodium channel Nav1.3 in rats.","date":"2025","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/40180210","citation_count":1,"is_preprint":false},{"pmid":"39612642","id":"PMC_39612642","title":"Fasting regulates expression of voltage-gated Na+ channel Nav1.3 in subfornical organ.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/39612642","citation_count":0,"is_preprint":false},{"pmid":"41725720","id":"PMC_41725720","title":"Toward precision medicine in SCN3A variants-associated encephalopathies and epilepsy: optimizing genetic diagnosis and molecular subregional effects.","date":"2026","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/41725720","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.28.685014","title":"The  <i>Onychomys</i>  pangenome reveals the unique molecular adaptations that confer toxin resistance","date":"2025-10-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.28.685014","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.16.670673","title":"Ancestral intronic splicing regulatory elements in the SCNα gene family","date":"2025-08-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.16.670673","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.24.661373","title":"Spatial transcriptomic profiling of human paravertebral sympathetic chain ganglia reveals diabetes-induced neuroplasticity","date":"2025-06-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.24.661373","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.20.602911","title":"DREAMER: Exploring Common Mechanisms of Adverse Drug Reactions and Disease Phenotypes through Network-Based Analysis","date":"2024-07-22","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.20.602911","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":41977,"output_tokens":9270,"usd":0.132491,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19529,"output_tokens":5452,"usd":0.116972,"stage2_stop_reason":"end_turn"},"total_usd":0.249463,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"Nav1.3 channels expressed in HEK293 cells generate fast-activating and fast-inactivating currents with rapid repriming at negative potentials, slow closed-state inactivation, and large ramp currents in response to slow depolarizations. Coexpression of β3 subunits had small but significant effects on kinetic and voltage-dependent properties, while β1 and β2 subunits had little or no effect. Repriming kinetics were twofold faster when Nav1.3 was expressed in SNS-null DRG neurons compared to HEK293 cells, demonstrating that cellular background modulates channel properties.\",\n      \"method\": \"Whole-cell patch clamp electrophysiology in HEK293 cells and SNS-null DRG neurons (via biolistics); TTX-resistant Nav1.3 mutant construct; coexpression of β subunits\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiological characterization with multiple conditions, subunit coexpression, and cell-type comparison in a single rigorous study\",\n      \"pmids\": [\"11487618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Human Nav1.3 expressed in CHO cells forms rapidly inactivating channels. Coexpression of β1 or β3 subunits shifted the inactivation curve ~10 mV negative and slowed repriming ~3-fold, whereas β2 had no effect alone or in combination with β1 or β3.\",\n      \"method\": \"Whole-cell patch clamp electrophysiology in stably transfected CHO cells; coexpression of β1, β2, and β3 subunits\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiological characterization with multiple subunit conditions, independent replication of β-subunit effects consistent with PMID:11487618\",\n      \"pmids\": [\"12220575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Intrathecal antisense oligodeoxynucleotides targeting Nav1.3 reduced Nav1.3 mRNA and protein in dorsal horn neurons, decreased hyperexcitability of multireceptive nociceptive neurons, and attenuated mechanical allodynia and thermal hyperalgesia after spinal cord injury (SCI) in rats. Effects reversed after cessation of antisense delivery, establishing a functional link between Nav1.3 upregulation in second-order dorsal horn neurons and central neuropathic pain after SCI.\",\n      \"method\": \"Intrathecal antisense ODN knockdown; extracellular electrophysiological recordings of dorsal horn neurons; quantitative RT-PCR, in situ hybridization, immunocytochemistry; behavioral pain assays in rat SCI model\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — antisense knockdown with multiple orthogonal readouts (molecular, electrophysiological, behavioral), reversal controls included\",\n      \"pmids\": [\"14523090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Lidocaine inhibited peak Nav1.3 current, shifted steady-state inactivation to hyperpolarized potentials, and delayed recovery from inactivation in Xenopus oocytes. These effects were attenuated by coexpression of β1 or β3, with β1 producing greater attenuation including reduced use-dependent block.\",\n      \"method\": \"Two-electrode voltage clamp in Xenopus oocytes; coexpression of β1 and β3 subunits; use-dependent block protocol\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous electrophysiology but single study, Xenopus oocyte system\",\n      \"pmids\": [\"12706451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Contactin coimmunoprecipitates with Nav1.3 from postnatal rat brain and from HEK293 cells stably expressing Nav1.3. GST fusion proteins of the N and C termini of Nav1.3 pull down contactin from HEK293 cell lysates. Cotransfection of contactin increases Nav1.3 current amplitude ~3-fold without changing biophysical channel properties. Enzymatic removal of contactin from the cell surface did not reduce elevated Nav1.3 current, suggesting contactin increases intracellular channel density at the surface rather than acting as a direct extracellular modulator.\",\n      \"method\": \"Co-immunoprecipitation from rat brain and HEK293 cells; GST pulldown; whole-cell patch clamp; enzymatic contactin removal; immunocytochemistry\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP and GST pulldown plus functional electrophysiology and enzymatic removal experiment, multiple orthogonal methods in one study\",\n      \"pmids\": [\"15317864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"After spinal cord contusion injury in rats, Nav1.3 protein is upregulated in thalamic VPL and VPM neurons, and these neurons show increased spontaneous discharge, afterdischarge, hyperresponsiveness to peripheral stimuli, and expanded receptive fields. Intrathecal antisense ODNs targeting Nav1.3 reduced Nav1.3 expression in thalamic neurons and reversed these electrophysiological alterations, linking Nav1.3 upregulation to altered thalamic somatosensory processing after SCI.\",\n      \"method\": \"Intrathecal antisense ODN knockdown; extracellular unit recordings in thalamic VPL neurons; immunocytochemistry; spinal cord transection control experiment in rats\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — antisense knockdown with electrophysiological reversal and anatomical controls, multiple orthogonal readouts\",\n      \"pmids\": [\"16109750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nav1.3 vasa recta (descending vasa recta) pericyte currents are regulated by calmodulin (CaM): CaM binds to the C-terminal domain of Nav1.3 via pulldown and co-immunoprecipitation assays. Calmodulin inhibitory peptide (CIP) and the CaM inhibitor W7 suppressed Nav1.3 currents in patch clamp. Raising intracellular Ca2+ from 20 to ~2000 nM produced a depolarizing shift in Nav1.3 activation.\",\n      \"method\": \"RT-PCR identification of Nav1.3 in DVR; immunoblot and immunofluorescence; GST-Nav1.3 C-terminal pulldown; co-immunoprecipitation; patch-clamp electrophysiology with CaM inhibitors and Ca2+ manipulation\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus GST pulldown plus functional electrophysiology, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"16912065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The novel SCN3A variant K354Q (K345Q in Nav1.3 DI/S5-6 linker) was identified in a pediatric epilepsy patient. Functional analysis in the Nav1.5 backbone demonstrated increased persistent current of a magnitude similar to epileptogenic SCN1A/SCN2A mutations, suggesting pathogenicity.\",\n      \"method\": \"Patient sequencing; heterologous functional expression and whole-cell patch clamp (in Nav1.5 backbone as surrogate)\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — functional analysis performed in a surrogate channel backbone (Nav1.5), not directly in Nav1.3; single study\",\n      \"pmids\": [\"18242854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The K354Q epilepsy-linked mutation directly assessed in Nav1.3 enhances both persistent and ramp currents of Nav1.3, reduces current threshold, and produces spontaneous firing and paroxysmal depolarizing shift-like complexes when Nav1.3/K354Q is expressed in hippocampal neurons.\",\n      \"method\": \"Site-directed mutagenesis; heterologous expression in HEK293 cells; whole-cell patch clamp; expression in hippocampal neurons by transfection\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution with mutagenesis in native Nav1.3 backbone plus functional neuronal readout, single lab but two orthogonal systems (HEK + neurons)\",\n      \"pmids\": [\"20420834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TNF-α upregulates Nav1.3 in DRG neurons: peri-sciatic administration of recombinant TNF-α without nerve injury upregulated Nav1.3 mRNA and protein and increased TTX-sensitive current densities in DRG neurons in vivo. TNF-α also dose-dependently enhanced Nav1.3 expression in cultured adult DRG neurons in vitro. Upregulation after L5 ventral root transection was significantly reduced in TNF receptor 1 knockout mice.\",\n      \"method\": \"In vivo recombinant TNF-α administration; in vitro DRG neuron culture with TNF-α; quantitative RT-PCR; immunocytochemistry; patch clamp; TNF receptor 1 knockout mice\",\n      \"journal\": \"Pain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (in vivo, in vitro, KO mice), replicated across conditions\",\n      \"pmids\": [\"20638792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Inhibition of NF-κB (via PDTC) prevented the re-expression of Nav1.3 induced by L5 ventral root transection and blocked the Nav1.3 upregulation caused by TNF-α in cultured DRG neurons, placing NF-κB downstream of TNF-α in the signaling pathway that drives Nav1.3 re-expression in sensory neurons after nerve injury.\",\n      \"method\": \"Intrathecal PDTC injection in rat VRT model; cultured adult DRG neurons treated with recombinant TNF-α ± PDTC; immunocytochemistry for Nav1.3; behavioral allodynia assays\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis by pharmacological NF-κB inhibition in vivo and in vitro, single lab, two complementary systems\",\n      \"pmids\": [\"20858468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The β3 subunit depolarizes voltage sensitivity of Nav1.3 activation and inactivation, induces biphasic inactivation with a novel slower component, and increases the fraction of channels inactivating by the slower pathway. NMR/CD structural analysis of the β3 intracellular domain revealed a short amphipathic α-helix followed by a disordered region; both regions selectively stabilize fast inactivation of Nav1.3.\",\n      \"method\": \"Whole-cell patch clamp in HEK293 cells; CD and NMR spectroscopy of β3 intracellular domain; deletion mutagenesis of β3 intracellular regions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — electrophysiology + NMR/CD structural analysis + mutagenesis, single lab but three orthogonal methods\",\n      \"pmids\": [\"20675377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PKC inhibition (staurosporine or calphostin C) in Nav1.3-expressing CHO cells caused a depolarizing shift in voltage dependence and decreased current amplitude, demonstrating that Nav1.3 channel function is regulated by PKC. In neuropathic DRG neurons, PKC inhibition reduced P2X-evoked TTX-sensitive sodium channel activity and reversed hyperexcitability.\",\n      \"method\": \"Whole-cell patch clamp in CHO cells stably expressing Nav1.3; PKC inhibitors (staurosporine, calphostin C); patch clamp of DRG neurons from spinal nerve ligation model; in situ hybridization for Nav1.3\",\n      \"journal\": \"Molecular pain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct pharmacological modulation of Nav1.3 in stable cell line plus DRG recordings, single lab, two systems\",\n      \"pmids\": [\"21314936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TNF-α-induced re-expression of Nav1.3 in cultured adult DRG neurons requires activation of both p38 MAPK and JNK: pharmacological inhibition of p38 MAPK (SB203580) or JNK (SP600125) dose-dependently blocked Nav1.3 re-expression triggered by recombinant TNF-α.\",\n      \"method\": \"Cultured adult rat DRG neurons; recombinant TNF-α treatment; p38 MAPK inhibitor SB203580 and JNK inhibitor SP600125; immunocytochemistry for Nav1.3\",\n      \"journal\": \"The Chinese journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological epistasis with two kinase inhibitors, in vitro single lab\",\n      \"pmids\": [\"22129822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The Nav1.3 pharmacological modulator BmK AS (scorpion toxin, site 4-specific) hyperpolarized voltage dependence of steady-state activation and inactivation, accelerated recovery from inactivation, and preferentially inhibited slow inactivation over fast inactivation, suggesting BmK AS stabilizes both closed and open states of Nav1.3.\",\n      \"method\": \"Two-electrode voltage clamp in Xenopus oocytes expressing Nav1.3; concentration-response analysis of BmK AS\",\n      \"journal\": \"Neuroscience bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct electrophysiological characterization of toxin-Nav1.3 interaction, single lab, single system\",\n      \"pmids\": [\"22622820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Four novel SCN3A missense variants (R357Q, D766N, E1111K, M1323V) and the previously reported K354Q variant, expressed as human Nav1.3 in heterologous cells, showed heterogeneous but overlapping functional defects. All variants shared increased current activation in response to depolarizing ramp voltages. R357Q had reduced current density and slower activation; E1111K produced increased persistent sodium current. This common ramp-current gain of function is consistent with neuronal hyperexcitability.\",\n      \"method\": \"Site-directed mutagenesis; heterologous expression of human Nav1.3 variants; whole-cell patch clamp in HEK293 or CHO cells\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct mutagenesis and electrophysiological characterization in native Nav1.3, multiple variants, single rigorous study\",\n      \"pmids\": [\"24157691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In mouse pancreatic α-cells, Nav1.3 (Scn3a) is the predominant voltage-gated sodium channel α-subunit; genetic ablation of Scn3a reduces the α-cell Na+ current by 80%. In β-cells, knockout of Scn3a reveals a small Scn3a-dependent Na+ current component. Glucagon and insulin secretion are inhibited in Scn3a-/- islets, establishing Nav1.3 as functionally important for islet hormone secretion.\",\n      \"method\": \"Single-cell PCR; Scn3a knockout mice; patch clamp of isolated α- and β-cells; glucagon/insulin secretion assays from isolated islets\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with electrophysiological and secretion readouts, multiple orthogonal methods, single rigorous study\",\n      \"pmids\": [\"25172946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CpG methylation of a specific site (-39C) in the Scn3a promoter represses promoter activity. MBD2 binds to the methylated -39C motif; knockdown of MBD2 in mouse cells led to -39C methylation and downregulation of Scn3a transcription. In seizure mice, demethylation of -39C and upregulation of Scn3a co-occur with decreased MBD2 binding, establishing an epigenetic CpG methylation/MBD2 mechanism for Scn3a expression control.\",\n      \"method\": \"Luciferase reporter assays; CpG methylation analysis; MBD2 knockdown in N1E-115 cells; chromatin pulldown/MBD2 binding assay; kainate seizure mouse model\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay + MBD2 knockdown + promoter methylation analysis, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"25459751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-96 directly inhibits Nav1.3 mRNA expression in embryonic DRG neurons in vitro and reduces Nav1.3 protein in DRG after CCI injury in vivo following intrathecal miR-96 administration.\",\n      \"method\": \"Intrathecal miR-96 delivery in CCI rat model; in vitro DRG neuron transfection; qRT-PCR and western blot for Nav1.3\",\n      \"journal\": \"Neurochemical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro knockdown, molecular readouts, single lab\",\n      \"pmids\": [\"24234845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Comparison of equivalent pore-region mutations in Nav1.1 (N301S) and Nav1.3 (N302S): SCN1A-N301S produced complete loss of function (no measurable sodium current), while SCN3A-N302S only slightly reduced channel activity, demonstrating that identical pore mutations have isoform-dependent electrophysiological consequences.\",\n      \"method\": \"Site-directed mutagenesis; heterologous expression; whole-cell patch clamp\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct mutagenesis and electrophysiology, single lab, single study\",\n      \"pmids\": [\"24990319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Valproate (but not carbamazepine or lamotrigine) epigenetically downregulates Scn3a expression by inducing methylation at the -39C site in the Scn3a promoter, decreasing promoter activity. VPA downregulates MBD2 at the posttranscriptional level, and MBD2 knockdown increases Scn3a expression. VPA also upregulates FTO protein; FTO knockdown abolishes VPA's repressive effects on MBD2 and Nav1.3.\",\n      \"method\": \"Luciferase reporter assays; CpG methylation analysis; MBD2 and FTO knockdown in Neuro-2a cells; western blot; real-time PCR; seizure mouse model\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple knockdown experiments plus reporter assays, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"27013471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A loss-of-function SCN3A variant (L247P) traffics deficiently to the cell surface (demonstrated by cell surface biotinylation), producing no detectable sodium current in heterologous expression. Heterozygous Scn3a hypomorphic (Scn3a+/Hyp) mice showed increased susceptibility to electroconvulsive and chemiconvulsive seizures and deficits in locomotor activity and motor learning, establishing that reduced Nav1.3 activity can increase seizure susceptibility.\",\n      \"method\": \"Whole-exome sequencing; heterologous expression + whole-cell patch clamp; cell surface biotinylation; Scn3a hypomorphic mouse line (gene trap); seizure threshold assays (6Hz, flurothyl, kainic acid); behavioral testing\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional characterization of trafficking defect plus in vivo mouse model with multiple seizure paradigms, multiple orthogonal methods\",\n      \"pmids\": [\"28235671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GAPDH binds to a conserved element in the 3' UTR of SCN3A mRNA, increasing Scn3a mRNA stability and expression. In seizure mice, upregulated and phosphorylated GAPDH enhances binding to the Scn3a 3' UTR, upregulating Scn3a. β-hydroxybutyric acid (produced by ketogenic diet) weakens GAPDH binding and rescues abnormal Scn3a expression.\",\n      \"method\": \"RNA-protein binding assays; mRNA stability assays; GAPDH knockdown; phosphorylation analysis; seizure and ketogenic diet mouse models; qRT-PCR\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-protein binding and mRNA stability assays with functional knockdown, single lab, two conditions\",\n      \"pmids\": [\"27816501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-30b overexpression attenuated Nav1.3 mRNA and protein expression in DRG neurons and spinal cord in a spinal nerve ligation neuropathic pain model. miR-30b agomir transfection down-regulated Nav1.3 stimulated by TNF-α in primary DRG neurons; miR-30b antagomir activated Nav1.3 expression.\",\n      \"method\": \"miR-30b agomir/antagomir transfection in primary DRG neurons; in vivo SNL model with intrathecal miR-30b delivery; western blot and qRT-PCR for Nav1.3; behavioral pain assays\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional miRNA manipulation (agomir and antagomir) in vitro and in vivo, single lab\",\n      \"pmids\": [\"28529474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"De novo pathogenic Nav1.3 variants (p.Ile875Thr, p.Pro1333Leu, p.Val1769Ala) associated with infantile epileptic encephalopathy showed prominent gain of channel function with markedly increased slowly inactivating persistent current and, for two variants, leftward shift in voltage dependence of activation. Antiseizure drugs phenytoin and lacosamide selectively blocked slowly inactivating over transient current in both wild-type and mutant Nav1.3.\",\n      \"method\": \"Whole-cell patch clamp electrophysiology of heterologously expressed mutant Nav1.3; pharmacological testing with phenytoin and lacosamide\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct mutagenesis and electrophysiology in native Nav1.3, multiple variants, pharmacological characterization, single rigorous study\",\n      \"pmids\": [\"29466837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Pathogenic Nav1.3 variants causing polymicrogyria of the perisylvian cortex exhibited increased persistent current in heterologous expression. SCN3A expression is highest in fetal cortical progenitor cells of the outer subventricular zone and cortical plate neurons and decreases postnatally. Expression of a mutant Nav1.3 channel in ferrets recapitulated disrupted cortical folding and neuronal migration, establishing a developmental role for Nav1.3 in progenitor cells and migrating neurons.\",\n      \"method\": \"Whole-cell patch clamp of mutant Nav1.3 in heterologous cells; immunostaining and in situ hybridization of human fetal cortex; in utero ferret electroporation of mutant channel; cortical histology\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — electrophysiology + human tissue expression + in vivo animal model, multiple orthogonal methods, single rigorous study\",\n      \"pmids\": [\"30146301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Nav1.3 is expressed in neutrophils recruited to ischemic mouse heart and kidney in vivo. Nav1.3-preferring inhibitors (ICA121431, Pterinotoxin-2) reduced endothelial adhesion, transmigration through endothelium, and chemotaxis of neutrophils in vitro, placing Nav1.3 as a regulator of neutrophil extravasation.\",\n      \"method\": \"PCR and flow cytometry of neutrophil Nav1.3 expression; mouse ischemia models; inhibitor treatment (TTX, ICA121431, Pterinotoxin-2, lidocaine); in vitro adhesion, transmigration, chemotaxis assays; whole-cell patch clamp of sodium currents\",\n      \"journal\": \"Anesthesiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays with selective inhibitors plus patch clamp, single lab\",\n      \"pmids\": [\"29509584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Extracellular acidosis produces a depolarizing shift in the voltage dependence of activation and moderate reduction in current density of Nav1.3, while voltage dependence of steady-state fast inactivation and recovery from fast inactivation are unchanged.\",\n      \"method\": \"Whole-cell patch clamp electrophysiology of Nav1.3 at varying extracellular pH\",\n      \"journal\": \"Channels (Austin, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct electrophysiological characterization, single lab, single method\",\n      \"pmids\": [\"30362397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Among 22 patients with pathogenic SCN3A variants, 10 of 11 tested pathogenic missense variants displayed gain of channel function (increased persistent current and/or leftward shift in voltage dependence of activation) when coexpressed with β1 and β2 subunits in HEK-293T cells. All variants associated with malformation of cortical development showed gain of function; variants clustering in transmembrane segments 4–6 of domains II–IV were most pathogenic.\",\n      \"method\": \"Whole-cell voltage clamp in HEK-293T cells coexpressing Nav1.3 with β1 and β2 subunits; systematic analysis of 11 pathogenic variants; patient cohort genotyping\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic electrophysiological characterization of 11 variants in native Nav1.3 with β subunits, large patient cohort, single rigorous multicenter study\",\n      \"pmids\": [\"32515017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miR-384-5p directly targets SCN3A as validated by dual-luciferase reporter assay. miR-384-5p agomir decreased Nav1.3 expression and alleviated mechanical allodynia and heat hyperalgesia in CCI rats.\",\n      \"method\": \"Dual-luciferase reporter assay; miR-384-5p agomir delivery in CCI rat model; western blot and qPCR for Nav1.3; behavioral pain assays\",\n      \"journal\": \"Neurological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase validation plus in vivo knockdown with functional readout, single lab\",\n      \"pmids\": [\"32098588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-214-3p targets Nav1.3 and TLR4 as validated by dual-luciferase reporter assay. Overexpression of miR-214-3p in STZ-induced diabetic neuropathy rats reduced Nav1.3 expression, reversed thermal hyperalgesia, and improved nerve conduction velocity.\",\n      \"method\": \"Dual-luciferase reporter assay; lentiviral miR-214-3p delivery; western blot; neurophysiological measurements; behavioral assays\",\n      \"journal\": \"Cell biology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase target validation plus in vivo functional readout, single lab\",\n      \"pmids\": [\"34296787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SIRT1 epigenetically regulates Nav1.3 in spinal CaMKIIα+ neurons: knockdown of spinal SIRT1 increased acetylation of histone H3 at the Scn3a promoter, increasing Nav1.3 expression and activating CaMKIIα+ neurons to cause neuropathic pain. Overexpression of SIRT1 reversed Nav1.3 upregulation and alleviated pain after CCI.\",\n      \"method\": \"ChIP-PCR for histone H3 acetylation at Scn3a promoter; co-immunoprecipitation; SIRT1 knockout (Sirt1loxP/loxP) and overexpression; chemogenetic activation/inhibition of CaMKIIα+ neurons; transcriptome sequencing; western blot; qRT-PCR; behavioral pain assays\",\n      \"journal\": \"CNS neuroscience & therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-PCR of specific promoter region + genetic KO + overexpression + co-IP, multiple orthogonal methods in single study\",\n      \"pmids\": [\"38828629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SCN3A-p.Ile875Thr iPSC-derived glutamatergic neurons (iNeurons) exhibit markedly increased slowly inactivating/persistent Na+ current, abnormal firing with paroxysmal bursting and plateau potentials, and a hyperpolarized voltage threshold for action potential generation compared to isogenic controls. The Nav1.3-selective blocker ICA-121431 normalized action potential threshold and aberrant firing in variant iNeurons, validating Nav1.3 as the mediator of pathological hyperexcitability.\",\n      \"method\": \"CRISPR/Cas9 gene editing of iPSCs; Ngn2-directed differentiation to iNeurons; whole-cell patch clamp electrophysiology; pharmacological blockade with ICA-121431; patient-derived iPSC isogenic control comparison\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — CRISPR-engineered isogenic human neurons plus patient-derived iPSC line, direct electrophysiology, pharmacological rescue, multiple orthogonal validations\",\n      \"pmids\": [\"37935051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Three novel SCN3A variants (p.L209P, p.N52H, p.E1809K) show distinct biophysical mechanisms: p.N52H reduced current density and hyperpolarized activation (mixed gain- and loss-of-function); p.L209P selectively hyperpolarized activation curve; p.E1809K altered fast inactivation and accelerated recovery kinetics. All were expressed in CHO cells with β1 subunits.\",\n      \"method\": \"Whole-cell patch clamp electrophysiology in CHO cells cotransfected with mutant Nav1.3 and β1 subunits; whole-exome sequencing; clinical phenotyping\",\n      \"journal\": \"Channels (Austin, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct electrophysiological characterization with mutagenesis, single lab, single study\",\n      \"pmids\": [\"41165134\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Nav1.3 (SCN3A) is a voltage-gated sodium channel α-subunit that generates rapidly activating, fast-inactivating, rapidly repriming TTX-sensitive Na+ currents with slow closed-state inactivation; its cell-surface expression is increased by the adhesion molecule contactin and its gating is modulated by β1/β3 auxiliary subunits (which slow repriming and shift inactivation) and by calmodulin binding to its C-terminus; in the developing brain Nav1.3 is highly expressed in progenitor cells and migrating cortical neurons where gain-of-function mutations cause polymicrogyria and epileptic encephalopathy through increased persistent current; after peripheral or central nerve injury, TNF-α acting via NF-κB and p38 MAPK/JNK signaling drives Nav1.3 re-expression in sensory and spinal neurons, and in the spinal dorsal horn SIRT1 loss leads to histone H3 acetylation at the Scn3a promoter and Nav1.3 upregulation—collectively producing neuronal hyperexcitability and neuropathic pain; Nav1.3 is also functionally expressed in pancreatic α-cells (where it is required for glucagon secretion) and neutrophils (where it regulates adhesion and transmigration).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SCN3A encodes Nav1.3, a voltage-gated sodium channel α-subunit that generates rapidly activating, fast-inactivating currents with rapid repriming at negative potentials, slow closed-state inactivation, and large ramp currents in response to slow depolarizations [#0, #1]. Channel behavior is shaped by auxiliary β-subunits: β1 and β3 shift steady-state inactivation negatively and slow repriming, with the β3 intracellular domain (a short amphipathic α-helix plus a disordered region) stabilizing fast inactivation, whereas β2 has little effect [#1, #11]. Cell-surface current is amplified by the adhesion molecule contactin, which binds the Nav1.3 N- and C-termini and increases functional channel density at the membrane without altering biophysical properties [#4], and channel gating is further modulated by calmodulin binding to the C-terminus and by PKC phosphorylation [#6, #12]. Nav1.3 plays a central developmental role: it is most highly expressed in fetal cortical progenitors and migrating cortical neurons, and gain-of-function variants that increase persistent and ramp current cause polymicrogyria and infantile epileptic encephalopathy, with the most pathogenic variants clustering in transmembrane segments 4–6 of domains II–IV [#24, #25, #28]. This gain-of-function mechanism produces neuronal hyperexcitability that has been recapitulated in patient-derived and isogenic iPSC neurons and reversed by the Nav1.3-selective blocker ICA-121431 [#32]. After nerve or spinal cord injury Nav1.3 is re-expressed in sensory and dorsal horn/thalamic neurons, driving hyperexcitability and neuropathic pain; this re-expression is driven by TNF-α signaling through NF-κB and p38 MAPK/JNK and is controlled epigenetically, including by SIRT1-dependent histone H3 acetylation at the Scn3a promoter [#2, #5, #9, #10, #13, #31]. Beyond the nervous system, Nav1.3 is the predominant sodium channel α-subunit in pancreatic α-cells where it is required for glucagon and insulin secretion, and it regulates neutrophil adhesion and transmigration [#16, #26].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established the intrinsic biophysical signature of Nav1.3 — fast activation/inactivation, rapid repriming, slow closed-state inactivation and large ramp currents — and showed cellular background modulates these properties, defining the channel's baseline behavior.\",\n      \"evidence\": \"Whole-cell patch clamp of TTX-resistant Nav1.3 in HEK293 and SNS-null DRG neurons with β-subunit coexpression\",\n      \"pmids\": [\"11487618\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"β-subunit effects were small in this system\", \"structural basis of slow closed-state inactivation not addressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Confirmed and quantified that β1 and β3, but not β2, modulate Nav1.3 inactivation voltage dependence and repriming, defining which auxiliary subunits shape channel kinetics.\",\n      \"evidence\": \"Whole-cell patch clamp in stably transfected CHO cells with β1/β2/β3 coexpression\",\n      \"pmids\": [\"12220575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"did not resolve structural mechanism of β-subunit action\", \"native neuronal β-subunit composition not determined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Linked Nav1.3 upregulation in second-order dorsal horn neurons to central neuropathic pain, moving the channel from a biophysical entity to a disease driver after spinal cord injury.\",\n      \"evidence\": \"Intrathecal antisense ODN knockdown with electrophysiological, molecular and behavioral readouts plus reversal controls in rat SCI model\",\n      \"pmids\": [\"14523090\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"upstream signal driving Nav1.3 upregulation not identified\", \"antisense specificity limits\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified contactin as a Nav1.3 interactor that increases surface channel density, providing a mechanism for regulating functional channel abundance distinct from gating modulation.\",\n      \"evidence\": \"Reciprocal Co-IP from rat brain and HEK293 cells, GST pulldown of N/C termini, patch clamp, and enzymatic surface removal\",\n      \"pmids\": [\"15317864\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"intracellular trafficking pathway not mapped\", \"physiological role of contactin–Nav1.3 in vivo not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended injury-driven Nav1.3 pathology to thalamic relay neurons, showing the channel alters supraspinal somatosensory processing after SCI.\",\n      \"evidence\": \"Antisense ODN knockdown with thalamic unit recordings and anatomical controls in rat SCI model\",\n      \"pmids\": [\"16109750\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism of remote thalamic upregulation unresolved\", \"no direct human correlate\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated calmodulin binds the Nav1.3 C-terminus and modulates current and Ca2+-dependent activation, adding a calcium-sensing layer to channel regulation.\",\n      \"evidence\": \"GST C-terminal pulldown, Co-IP, and patch clamp with CaM inhibitors and Ca2+ manipulation in vasa recta pericytes\",\n      \"pmids\": [\"16912065\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single lab, peripheral cell type\", \"structural CaM-binding determinants not mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established the canonical gain-of-function disease mechanism by showing an epilepsy-linked variant (K354Q) enhances persistent and ramp currents in native Nav1.3 and induces spontaneous neuronal firing.\",\n      \"evidence\": \"Site-directed mutagenesis with patch clamp in HEK293 cells and hippocampal neurons\",\n      \"pmids\": [\"20420834\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"genotype–phenotype generalization beyond one variant not yet established\", \"in vivo consequence not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined the inflammatory upstream pathway for injury-induced Nav1.3 re-expression, placing TNF-α (via TNFR1) and NF-κB as drivers in sensory neurons.\",\n      \"evidence\": \"In vivo/in vitro recombinant TNF-α, TNFR1 knockout mice, NF-κB inhibitor PDTC, with molecular and electrophysiological readouts\",\n      \"pmids\": [\"20638792\", \"20858468\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct transcription factor binding to Scn3a promoter not shown\", \"NF-κB epistasis was pharmacological\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Resolved the structural basis of β3-mediated gating control, showing its amphipathic helix and disordered region stabilize fast inactivation of Nav1.3.\",\n      \"evidence\": \"Patch clamp plus CD/NMR of β3 intracellular domain and deletion mutagenesis in HEK293 cells\",\n      \"pmids\": [\"20675377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"full channel–β3 complex structure not determined\", \"in vivo relevance of biphasic inactivation unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Added kinase regulation (p38 MAPK/JNK downstream of TNF-α; PKC modulation of gating) to the network controlling Nav1.3 expression and function in neuropathic states.\",\n      \"evidence\": \"Pharmacological kinase inhibition in cultured DRG neurons and PKC inhibitors in stable CHO Nav1.3 cells with patch clamp\",\n      \"pmids\": [\"22129822\", \"21314936\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"direct phosphorylation sites on Nav1.3 not mapped\", \"pharmacological inhibitor specificity\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Generalized the gain-of-function model by showing a panel of SCN3A epilepsy variants share increased ramp-current activation despite heterogeneous individual defects.\",\n      \"evidence\": \"Site-directed mutagenesis and patch clamp of multiple human Nav1.3 variants in HEK293/CHO cells\",\n      \"pmids\": [\"24157691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanistic basis for shared ramp current not resolved\", \"no in vivo modeling of these variants\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed multilayered post-transcriptional and epigenetic control of Scn3a — CpG methylation/MBD2, GAPDH binding to the 3'UTR, and microRNA targeting — establishing how channel abundance is tuned in seizure and pain states.\",\n      \"evidence\": \"Reporter assays, MBD2/GAPDH knockdown, RNA-protein binding, mRNA stability assays, and miRNA delivery across seizure and CCI models\",\n      \"pmids\": [\"25459751\", \"27816501\", \"24234845\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"relative contribution of each regulatory layer in vivo unclear\", \"single-lab findings for individual mechanisms\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified a non-neuronal physiological role: Nav1.3 is the dominant α-cell sodium channel and is required for islet glucagon and insulin secretion.\",\n      \"evidence\": \"Single-cell PCR, Scn3a knockout mice, patch clamp of α/β cells, and hormone secretion assays\",\n      \"pmids\": [\"25172946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"coupling between Nav1.3 current and secretory machinery not detailed\", \"human islet relevance not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed that loss-of-function Nav1.3 (trafficking-deficient L247P; hypomorphic mice) can also increase seizure susceptibility, revealing that both gain and loss of channel activity disrupt network excitability.\",\n      \"evidence\": \"Heterologous expression, surface biotinylation, and Scn3a hypomorphic mouse seizure-threshold and behavioral testing\",\n      \"pmids\": [\"28235671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism reconciling gain- and loss-of-function phenotypes unresolved\", \"trafficking defect not localized to a specific step\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established Nav1.3 as a developmental channel whose persistent-current gain-of-function variants cause polymicrogyria by disrupting cortical neuronal migration and folding.\",\n      \"evidence\": \"Patch clamp of variants, human fetal cortex expression mapping, and in utero ferret electroporation recapitulating cortical malformation\",\n      \"pmids\": [\"30146301\", \"29466837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how sodium current influences migration mechanistically not defined\", \"progenitor-cell function of the channel unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended Nav1.3 function to innate immunity, implicating it in neutrophil adhesion, transmigration and chemotaxis during ischemic injury.\",\n      \"evidence\": \"Neutrophil expression profiling, mouse ischemia models, selective inhibitors, and in vitro migration assays with patch clamp\",\n      \"pmids\": [\"29509584\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"downstream signaling linking Nav1.3 to motility unknown\", \"inhibitor selectivity caveats\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematized genotype–phenotype correlation by showing nearly all cortical-malformation–associated variants are gain-of-function and localize to domain II–IV S4–S6 segments.\",\n      \"evidence\": \"Whole-cell voltage clamp of 11 variants coexpressed with β1/β2 in HEK-293T cells across a 22-patient cohort\",\n      \"pmids\": [\"32515017\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanistic link between channel locus and phenotype severity not fully explained\", \"loss-of-function variants underrepresented\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Provided human-cell validation that a recurrent variant drives pathological hyperexcitability via persistent current, with pharmacological rescue confirming Nav1.3 causality.\",\n      \"evidence\": \"CRISPR isogenic and patient-derived iPSC glutamatergic neurons, patch clamp, and ICA-121431 rescue\",\n      \"pmids\": [\"37935051\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"network/circuit-level consequences in human tissue not tested\", \"single variant studied\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified a specific epigenetic switch (SIRT1-dependent histone H3 acetylation at the Scn3a promoter) controlling injury-induced Nav1.3 upregulation in defined spinal neuron populations.\",\n      \"evidence\": \"ChIP-PCR, SIRT1 knockout/overexpression, Co-IP, chemogenetics in CaMKIIα+ neurons, and behavioral pain assays in CCI model\",\n      \"pmids\": [\"38828629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct SIRT1 substrate at the promoter not defined\", \"integration with TNF-α/NF-κB axis not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the same channel produces opposing gain- and loss-of-function disease phenotypes and how Nav1.3 sodium influx mechanistically controls non-electrical processes such as cortical progenitor behavior, neutrophil migration, and islet hormone secretion.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"no unifying mechanism for gain- vs loss-of-function epilepsy outcomes\", \"molecular coupling of Na+ current to migration/secretion/motility undefined\", \"no high-resolution structure of Nav1.3 with auxiliary partners in the timeline\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 16]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 24, 32]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 25, 32]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CNTN1\",\n      \"SCN1B\",\n      \"SCN3B\",\n      \"CALM1\",\n      \"SCN2B\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}